While AstraZeneca CEO Pascal Soriot's proposed pay package has attracted criticism ahead of the company's annual meeting, a large investor... Read this story
While AstraZeneca CEO Pascal Soriot's proposed pay package has attracted criticism ahead of the company's annual meeting, a large investor... Read this story
More from Fierce Pharma | Pascal Soriot CEO pay AstraZeneca Fierce Pharma Homepage Pharma Dividend